Log in

688837 EVOPOINT BIOSCIENCES CO LTD SSE · China

EVOPOINT BIOSCIENCES CO LTD (688837) news

EVOPOINT BIOSCIENCES CO LTD is a public biotech or pharmaceutical company listed on SSE under the ticker 688837, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest EVOPOINT BIOSCIENCES CO LTD news

We have not published a story on EVOPOINT BIOSCIENCES CO LTD yet. When there is news, it will appear here.

Questions about EVOPOINT BIOSCIENCES CO LTD

What is the ticker symbol of EVOPOINT BIOSCIENCES CO LTD?

EVOPOINT BIOSCIENCES CO LTD trades under the ticker 688837 on SSE.

Where is EVOPOINT BIOSCIENCES CO LTD listed?

EVOPOINT BIOSCIENCES CO LTD is listed on SSE.

Which country or territory is EVOPOINT BIOSCIENCES CO LTD listed under?

Our directory records EVOPOINT BIOSCIENCES CO LTD under China.

What does EVOPOINT BIOSCIENCES CO LTD do?

Our directory classifies EVOPOINT BIOSCIENCES CO LTD as: Biotechnology. This is a directory classification, not a description of the pipeline.

Does aibio.space cover EVOPOINT BIOSCIENCES CO LTD?

aibio.space lists EVOPOINT BIOSCIENCES CO LTD among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to EVOPOINT BIOSCIENCES CO LTD?

Companies in our directory listed in the same country and business area as EVOPOINT BIOSCIENCES CO LTD: Boji Medical Technology Co., Jiangsu gdk Biotechnology Co., Zhejiang Hengtong Holding Co., Frontier Biotechnologies, XtalPi Holdings, Wuhan Healthgen Biotechnology.

Investor discussion: EVOPOINT BIOSCIENCES CO LTD

Members talk about EVOPOINT BIOSCIENCES CO LTD (688837). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688837 on TradingView.

Listing details

EVOPOINT BIOSCIENCES CO LTD is a public biotech or pharmaceutical company listed on SSE under the ticker 688837, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
EVOPOINT BIOSCIENCES CO LTD
Ticker
688837
Listing
SSE
Country or territory
China
Business scope
Biotechnology
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.